NTBL - Notable Labs, Ltd. Quarterly Revenue Growth

Public company logo of Notable Labs Inc. (NTBL)

Notable Labs, Ltd. (NTBL) is advancing precision oncology through partnerships with medical centers to predict chemotherapy success. The company is diversifying risks by offering pharmaceutical behemoths personalized therapy selection for blood cancer. The quarterly revenue growth rate illustrates a fundamental development trend, where 0.00 determines this parameter level. The business is currently expanding its network of B2B contracts with hospitals, validating its IT tumor analysis models.

NTBL (Notable Labs Inc.) Revenue Growth QoQ history from 02/21/2024 to 11/02/2024

Analytical breakdowns and data insights for company Notable Labs Inc. (NTBL)

- share price and expert price forecast:
- money and cash flow information:
General company analysis:NTBL - Notable Labs, Ltd.
Manufactured products of Notable Labs Ltd

To find a balance between asset value and business quality, assessing the rate of capital inflow is critical, where quarterly revenue growth serves as a marker for cash flow resilience against market volatility. In the absence of commercial products from Notable Labs, Ltd. (NTBL), current quarterly revenue trends reflect a dependence on clinical trial funding and the patenting of AI analysis, signaling the model's viability prior to FDA approval.

Competitor analysis for Notable Labs, Ltd.

BeiGene Oncology - Quarterly Revenue Growth|HALO: Revenue Growth QoQ|Revolution Medicines Corp (RVMD) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Ascentage Pharma Group International (AAPG)|Revenue Growth QoQ CG Oncology, Inc.|Quarterly Revenue Growth Rate UroGen Pharma Corp URGN|Quarterly Revenue Growth BCAX|Personalis, Inc. - Sales Growth QoQ|Erasca - Quarterly Sales Growth|Quarterly Revenue Increase DCTH|YMAB: Quarterly Sales Growth|Quarterly Revenue Growth Rate Aura Corp|CADL: Quarterly Revenue Growth|ARAY - Quarterly Sales Growth Rate|SLS (SELLAS Life Sciences Group, Inc.) - Quarterly Revenue Growth|ACTU: Quarterly Revenue Increase|Revenue Growth QoQ citiusonc.com (CTOR)|Quarterly Sales Growth Rate TuHURA Biosciences|Revenue Growth QoQ Protara Therapeutics TARA|Fate Therapeutics (FATE) - Quarterly Revenue Growth Rate|WHWK - Revenue Growth QoQ|Quarterly Revenue Growth Rate TScan Therapeutics Inc|championsoncology.com (CSBR) - Revenue Growth QoQ|Sales Growth QoQ XBIT|Quarterly Sales Growth CVM|Sales Growth QoQ OSTX (OS Therapies Incorporated)|Quarterly Revenue Growth RADX|ARTV: Revenue Dynamics QoQ|Quarterly Revenue Growth ANL (Adlai Nortye Ltd)|VERU - Quarterly Sales Growth|tempesttx.com - Quarterly Revenue Growth|Quarterly Revenue Increase XLO (xiliotx.com)|RENB: Quarterly Revenue Growth|Quarterly Sales Growth Mural Oncology plc|Revenue Growth QoQ Kairos Pharma Inc|OKUR: Quarterly Revenue Increase|Quarterly Revenue Growth GDTC|CRIS (Curis) - Quarterly Revenue Increase|Revenue Growth QoQ apollomicsinc.com APLM|THAR: Sales Growth QoQ|advanbiomed.com - Quarterly Revenue Growth|Quarterly Revenue Increase GNPX (Genprex, Inc)|Calidi Biotherapeutics Inc. (CLDI) - Revenue Growth QoQ|Sunshine Biopharma Inc. (SBFM) - Quarterly Revenue Growth|XBIO (Xenetic Bio) - Quarterly Revenue Growth|Salarius Pharmaceuticals Inc (SLRX) - Quarterly Sales Growth Rate|Quarterly Revenue Growth PPBT|Quarterly Revenue Growth American Oncology Network Inc (AONC)|Quarterly Revenue Growth BGNE (BeiGene Ltd.)|Sales Change QoQ CKPT (Checkpoint Therapeutics)|ELEV - Revenue Growth QoQ|ICAD (iCAD Inc.) - Sales Growth QoQ|Ikena (IKNA) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Viracta (VIRX)|MOR (MorphoSys AG) - Quarterly Revenue Growth|NAYA: Quarterly Revenue Increase|Revenue Growth QoQ Ascentage Pharma Group Ltd (AAPGV)